{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:48:43Z","timestamp":1790621323996,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejpn.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T17:35:36Z","timestamp":1471714536000},"page":"816-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment of autistic spectrum disorder with insulin-like growth factors"],"prefix":"10.1016","volume":"20","author":[{"given":"Raili","family":"Riikonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2016.08.005_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fped.2014.00061","article-title":"New experimental treatments for core social domain in autism spectrum disorders","volume":"2","author":"Canitano","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ejpn.2016.08.005_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WCO.0000000000000186","article-title":"Autism and the synapse: emerging mechanisms and mechanism-based therapies","volume":"28","author":"Ebrahimi-Fakhari","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10110","article-title":"Transcriptomic analysis of autistic brain reveals convergant molecular pathology","volume":"474","author":"Voineagu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejpn.2016.08.005_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature11860","article-title":"Activity-dependent neuronal signaling and autism spectrum disorder","volume":"493","author":"Ebert","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejpn.2016.08.005_bib5","series-title":"The IGF system: molecular biology, physiology, and clinical application","first-page":"425","article-title":"IGFs and the nervous system","author":"Leventhal","year":"1999"},{"key":"10.1016\/j.ejpn.2016.08.005_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/er.2004-0024","article-title":"The insulin-like growth factor system and its pleiotropic functions in the brain","volume":"26","author":"Russo","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejpn.2016.08.005_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0306-4522(92)90193-6","article-title":"Cellular patterns of type -1 insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison of insulin-like growth factors I and II","volume":"46","author":"Bondy","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejpn.2016.08.005_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00005072-199207000-00009","article-title":"Insulin-like growth factor II expression in the developing brain","volume":"51","author":"McKelvie","year":"1992","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib9","doi-asserted-by":"crossref","first-page":"E1647","DOI":"10.1152\/ajpendo.00674.2006","article-title":"The rapid activation of protein synthesis by growth hormone requires signaling through mTOR","volume":"292","author":"Hayashi","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejpn.2016.08.005_bib10","first-page":"103","article-title":"Protective effects of the GH\/IGF-1 axis on the brain","volume":"32","author":"Iscgaard","year":"2007","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrendo.2013.78","article-title":"Growth hormone and cognitive function","volume":"9","author":"Nyberg","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ecl.2012.04.016","article-title":"Insulin-like growth factor-1 and central neurodegenerative disease","volume":"41","author":"Torres-Aleman","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl. 5","key":"10.1016\/j.ejpn.2016.08.005_bib13","first-page":"1243","article-title":"Consequences of not treating children with Laron syndrome (primary growth hormone insensivity)","volume":"14","author":"Laron","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ejpn.2016.08.005_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1528-1167.2009.02499.x","article-title":"Insulin-like growth factor is associated with cognitive outcome in infantile spasms","volume":"51","author":"Riikonen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2016.08.005_bib15","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1528-1167.2008.01688.x","article-title":"Risk of autism spectrum disorders after infantile spasms: a population-based study nested in a cohort with seizures in the first year of life","volume":"49","author":"Saemundsen","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2016.08.005_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1017\/S0012162206001605","article-title":"Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism","volume":"48","author":"Riikonen","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib17","first-page":"289","article-title":"Neurotrophic effect of antidepressant drugs","volume":"29","author":"Castren","year":"2004","journal-title":"Neurobiology"},{"key":"10.1016\/j.ejpn.2016.08.005_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/MN:29:3:289","article-title":"Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection","volume":"29","author":"Castren","year":"2004","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11530010-000000000-00000","article-title":"Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment","volume":"24","author":"Castren","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejpn.2016.08.005_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0031-1291242","article-title":"Effects of fluoxethine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism","volume":"42","author":"Makkonen","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2016.08.005_bib21","first-page":"1","article-title":"Brain derived neurotrophic factor and serotonin binding markers of clinical response to fluoxethine therapy in children with autism","volume":"9","author":"Makkonen","year":"2011","journal-title":"J Ped Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib22","unstructured":"Schilling, Blum W, Heuser I, et\u00a0al. Treatment with antidepressants increases insulin-like growth factor-1."},{"key":"10.1016\/j.ejpn.2016.08.005_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0887-8994(96)00218-4","article-title":"High levels of cerebrospinal fluid glutamate in Rett syndrome","volume":"15","author":"Lappalainen","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0306-4522(97)00367-9","article-title":"Insulin-like growth factor is developmentally stage-dependent and mediated by specific intracellular pathways","volume":"83","author":"Torres-Aleman","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejpn.2016.08.005_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.21562","article-title":"Brain metabolism in Rett syndrome: age, clinical, and phenotype correlations","volume":"65","author":"Horschka","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib26","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib27","unstructured":"Naidu, et\u00a0al. Clin.Trials.gov, NCT 00593957."},{"key":"10.1016\/j.ejpn.2016.08.005_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jnr.21620","article-title":"Ciliary neurotrophic factor and interleukin-6 differently activate microglia","volume":"86","author":"Krady","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ejpn.2016.08.005_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-8-12","article-title":"Central administration of insulin-like growth factor-1 decreases depressive-like behavior and brain cytokine expression in mice","volume":"8","author":"Park","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ejpn.2016.08.005_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neurogial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2016.08.005_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","article-title":"Insulin-like growth factor 1 (IGF1) and its active peptide (1-3) IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms","volume":"520","author":"Corvin","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ejpn.2016.08.005_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/485570a","article-title":"Microglia","volume":"485","author":"Hughes","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejpn.2016.08.005_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2202-11-132","article-title":"Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression","volume":"11","author":"Jacobs","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2040-2392-4-9","article-title":"Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay","volume":"9","author":"Bozdagi","year":"2013","journal-title":"Mol Autism"},{"key":"10.1016\/j.ejpn.2016.08.005_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijdevneu.2014.03.006","article-title":"Dysregulation of the IGF-I\/PI3K\/AKT\/mTOR signaling pathway in autism spectrum disorders","volume":"35","author":"Chen","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib36","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/jcp.24607","article-title":"IGF-1 allevates NMDA-induced excitotocity in cultured hippocampal neurons against autophagy via NR2B\/Pi3K-AKT-mTOR pathway","volume":"229","author":"Wang","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1017\/S0012162201001116","article-title":"Low levels of insulin-like growth factor-1 in the cerebrospinal fluid in children with autism","volume":"43","author":"Vanhala","year":"2001","journal-title":"Dev Med Child Neuro"},{"key":"10.1016\/j.ejpn.2016.08.005_bib38","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MECP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.ejpn.2016.08.005_bib39","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for treatment of Rett syndrome","volume":"25","author":"Khwaja","year":"2014","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"1","key":"10.1016\/j.ejpn.2016.08.005_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2040-2392-5-54","article-title":"A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome","volume":"5","author":"Kolevzon","year":"2014","journal-title":"Mol Autism"},{"key":"10.1016\/j.ejpn.2016.08.005_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nature12618","article-title":"SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome","volume":"503","author":"Shcheglovitov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejpn.2016.08.005_bib42","first-page":"553","article-title":"Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency","volume":"5","author":"Fintini","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ejpn.2016.08.005_bib43","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","article-title":"Correlations of receptor binding and mitogenic potencies of insulin analogs designed for clinical use","volume":"49","author":"Kurtzhals","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ejpn.2016.08.005_bib44","first-page":"679801","article-title":"IGF1 as a potential treatment for Rett syndrome; safety assessment in six Rett patients","author":"Pini","year":"2012","journal-title":"Autism Res Treat"},{"key":"10.1016\/j.ejpn.2016.08.005_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fped.2014.00052","article-title":"Repeated insulin-like growth factor 1 treatment in a patient with Rett syndrome: a single case study","volume":"2","author":"Pini","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ejpn.2016.08.005_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/joe.0.1460141","article-title":"Enzymatic conversion of IGF-1 to des (1-3) IGF-1 in rat serum and tissues: a further potential site of growth hormone regulation of IGF-1 action","volume":"146","author":"Yamamoto","year":"1995","journal-title":"J Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2016.08.005_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2008.12.003","article-title":"NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in rat model of acute focal stroke","volume":"278","author":"Bickerdike","year":"2009","journal-title":"J Neorol Sci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-015-8341-2","article-title":"NNZ-2566, a novel analog of (1-3) IGF, as a potential therapeutic agent for fragile X syndrome","volume":"17","author":"Deacon","year":"2015","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.ejpn.2016.08.005_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-6-19","article-title":"NNZ 2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats","volume":"6","author":"Wei","year":"2009","journal-title":"J Neuroinflammation"},{"issue":"6039","key":"10.1016\/j.ejpn.2016.08.005_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult function requires MeCP2","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2016.08.005_bib51","first-page":"549","article-title":"Growth hormone (GH), brain development and neural stem cells","volume":"9","author":"Waters","year":"2011","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.ejpn.2016.08.005_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1100\/tsw.2006.22","article-title":"Aspects of growth hormone and insulin-like growth factor-1 related to neuroprotection,regeneration and functional plasticity in the adult brain","volume":"18","author":"\u00c5berg","year":"2006","journal-title":"Sci World J"},{"key":"10.1016\/j.ejpn.2016.08.005_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnins.2016.00052","article-title":"IGF-I: a key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain","volume":"10","author":"Nieto-Est\u00e9vez","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib54","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1523\/JNEUROSCI.20-08-02896.2000","article-title":"Peripheral infusion of IGF-1 selectively induces neurogenesis in the adul rat.hippocampus","volume":"15","author":"\u00c5berg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-15-100","article-title":"Growth hormone pathways signaling for cell proliferation and survival in hippocampal neural precursors from postnatal mice","volume":"15","author":"Devesa","year":"2014","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.ejpn.2016.08.005_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0074-7742(09)88014-8","article-title":"The role of the somatotropic axis in neuroprotection and neurodegeneration of the addictive brain","volume":"88","author":"Nyberg","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2011.05.029","article-title":"Growth hormone and prolactin regulate human neural stem cell regenerative activity","author":"Pathipati","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejpn.2016.08.005_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","article-title":"Neurodevelopmenta\u00f6 effects of insulin-like growth factor signaling","volume":"33","author":"O'Kusky","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stem.2010.04.016","article-title":"Signalling through BMPR-IA regulates quiescence and long-trm activity of neural stem cells in the adult hippocampus","volume":"7","author":"Mira","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejpn.2016.08.005_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neures.2013.03.014","article-title":"Role of growth hormone (GH) in the treatment on neural diseases: from neuroprotection to neural repair","volume":"76","author":"Arce","year":"2013","journal-title":"Neurosci Res"},{"key":"10.1016\/j.ejpn.2016.08.005_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yhbeh.2012.02.022","article-title":"Growth hormone and brain trauma","volume":"63","author":"Devesa","year":"2013","journal-title":"Horm Behav"},{"key":"10.1016\/j.ejpn.2016.08.005_bib62","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors in neoplasia","volume":"4","author":"Pollack","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejpn.2016.08.005_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncponc0934","article-title":"Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer","volume":"4","author":"Tao","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13131","article-title":"Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel","author":"Libruder","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejpn.2016.08.005_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-08-0201","article-title":"Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects","volume":"159","author":"Colao","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2011.03.003","article-title":"Is growth hormone resistance\/IGF-1 reduction good for you?","volume":"13","author":"Callagher","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejpn.2016.08.005_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2011-300265","article-title":"How to use insulin-like growth facture 1 (IGF1)","volume":"97","author":"Peters","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.ejpn.2016.08.005_bib68","doi-asserted-by":"crossref","DOI":"10.4158\/EP15939.RA","article-title":"Lessons from 50 years of study of Laron syndrome","author":"Laron","year":"2015","journal-title":"Endocrinol Pract"},{"issue":"70","key":"10.1016\/j.ejpn.2016.08.005_bib69","first-page":"ra 13","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging, cancer, and diabetes in humans","volume":"3","author":"Guevara- Arguire","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejpn.2016.08.005_bib70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2265.2007.02868.x","article-title":"Elevated levels of growth-related hormones in autism and autism spectrum disorder","volume":"67","author":"Mills","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib71","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijporl.2008.03.015","article-title":"Changes in serum levels of IGF-1 and growth following adeno-tonsillectomy in children","volume":"72","author":"Kang","year":"2008","journal-title":"Int J Ped Otorhinol"},{"key":"10.1016\/j.ejpn.2016.08.005_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijporl.2010.02.014","article-title":"Changes in serum IGF-1, and IGFB-3 levels and growth in children following adenoidectomy, tonsillectomy and tonsillectomy","volume":"74","author":"Kiris","year":"2010","journal-title":"Int J Pediatr Otorhinol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816301398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816301398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:35:05Z","timestamp":1568306105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379816301398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1090379816301398"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.08.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of autistic spectrum disorder with insulin-like growth factors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}